Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACIFIC-AMI Phase 2 Trial of Asundexian After Acute Myocardial Infarction
jRCT2080225213Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of asundexian in myocardial infarction (MI) (3 arms), sponsored by Bayer. Started Jun 2020; status: completed.
02
Drugs
asundexian
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCT2080225213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225213.